1
Orphan Designations
0
FDA Approvals
3
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| brain ischemia | Methyl O-4-O-[2-[2-[2-[2-[[N-[(1R)-1-[[4-(aminoiminomethyl)phenyl]methyl]-2-oxo-2-(1-piperidinyl)ethyl]-N2-[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]-L-?-aspararginyl-4-aminobutanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-lysyl]amino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-di-O-methyl-6-O-sulfo-?-D-glucopyranosyl-(1?4)-O-2,3-di-O-methyl-?-D-glucopyranuronosyl-(1?4)-O-2,3,6-tri-O-sulfo- ?-D-glucopyranosyl-(1?4)-O-2,3-di-O-methyl- ?-L-idopyranuronosyl-(1?4)-3-O | Orphan Designation | - |
| ischemia reperfusion injury | Methyl O-4-O-[2-[2-[2-[2-[[N-[(1R)-1-[[4-(aminoiminomethyl)phenyl]methyl]-2-oxo-2-(1-piperidinyl)ethyl]-N2-[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]-L-?-aspararginyl-4-aminobutanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-lysyl]amino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-di-O-methyl-6-O-sulfo-?-D-glucopyranosyl-(1?4)-O-2,3-di-O-methyl-?-D-glucopyranuronosyl-(1?4)-O-2,3,6-tri-O-sulfo- ?-D-glucopyranosyl-(1?4)-O-2,3-di-O-methyl- ?-L-idopyranuronosyl-(1?4)-3-O | Orphan Designation | - |
| retinal ischemia | Methyl O-4-O-[2-[2-[2-[2-[[N-[(1R)-1-[[4-(aminoiminomethyl)phenyl]methyl]-2-oxo-2-(1-piperidinyl)ethyl]-N2-[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]-L-?-aspararginyl-4-aminobutanoyl-N6-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-L-lysyl]amino]ethoxy]ethoxy]ethoxy]ethyl]-2,3-di-O-methyl-6-O-sulfo-?-D-glucopyranosyl-(1?4)-O-2,3-di-O-methyl-?-D-glucopyranuronosyl-(1?4)-O-2,3,6-tri-O-sulfo- ?-D-glucopyranosyl-(1?4)-O-2,3-di-O-methyl- ?-L-idopyranuronosyl-(1?4)-3-O | Orphan Designation | - |